Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

jj_2johnson_and_johnson

Johnson & Johnson’s Stelara receives FDA approval

September 27, 2016 Manufacturing and Production, Research and Development Janssen Biotech, Johnson & Johnson, Stelara

The drug is approved for use to treat the skin condition scaly plaque psoriasis and a type of arthritis associated …
News
biogen_austria_238

Biogen closes in on bringing muscular atrophy preventing drug to market

September 26, 2016 Manufacturing and Production, Research and Development Biogen, EMA, FDA, Nusinersen

Biogen has applied for Priority Review, which, if granted, would shorten the review period necessary for nusinersen. They also plan …
News

CPHI Worldwide: PCI to Share Expertise in Serialization and Safe Handling of Potent Molecules

September 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPhI

Leading pharmaceutical provider PCI Pharma Services will bring its expertise to the stage at CPHI Worldwide (Barcelona, October 4-6 2016) …
News
Press release
fda2outsideweb

Sanofi and Regeneron’s atopic dermatitis drug secures FDA priority review

September 26, 2016 Research and Development, Sales and Marketing

Regeneron and Sanofi have announced that the US Food and Drug Administration has granted priority review for the pair’s atopic …
News

Merck elects Isabel De Paoli as CSO

September 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, appointment

German pharma firm Merck has appointed Isabel De Paoli to the position of chief science officer in addition to her …
News
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

September 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday (and print day for the Pharmafocus October edition!) and its been a pretty explosive week, from new and …
News
alzheimers_brain

Alzheimer’s drug failure sends Lundbeck’s shares crashing

September 23, 2016 Medical Communications, Research and Development Alzheimer's, Lundbeck, cultural failings

Lundbeck’s experimental idalopirdine has failed to meet its primary endpoint in its first Phase III trial in the treatment of …
News
shutterstock_232245868

Novartis’ Zykadia smashes Phase III target for lung cancer

September 23, 2016 Medical Communications, Research and Development Novartis, lung cancer, zykadia

Novartis has announced that its cancer drug Zykadia (ceritinib) has achieved positive results in its Phase III clinical trial investigating …
News
shutterstock_359806121

DNA damage response biotech launches with £25m funding

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dna damage response, funding

Cambridge-based Artios Pharma has officially launched after raising £25 million in series A financing from US and European life science …
News
un_assembly

193 countries sign UN declaration to fight drug-resistant infection

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeremy Hunt, UN, drug-resistant infection

A historic UN declaration to fight drug-resistant infection across the globe has been signed by 193 countries at the United …
News
gilead-sciences

Gilead terminates Phase II/III study for ulcerative colitis antibody

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, ulcerative colitis

Gilead has put the brakes on a Phase II/III study of its anti-MMP9 antibody GS-5745 for the treatment of ulcerative …
News

AZ withdraws European filing for ovarian cancer therapy

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, cediranib, ovarian cancer

AstraZeneca is no longer seeker European approval for its oral multi-VEGF receptor inhibitor cediranib for treatment of ovarian cancer after withdrawing …
News
heather_bresch

EpiPen CEO appears before US lawmakers to defend “sickening” price hikes

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heather Bresch, Mylan, epipen

Disgraced Mylan CEO Heather Bresch (pictured) has appeared before US lawmakers to defend the company’s now infamous and much-maligned inflation …
News
2363

GSK appoints Emma Walmsley as first female CEO

September 21, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, appointment

GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …
Appointment
shutterstock_168864905

GE Healthcare doubles India investment

September 21, 2016 Manufacturing and Production, Research and Development, Sales and Marketing GE Healthcare, India

UK firm GE Healthcare is set to double its investment in India as it aims for revenues of £750 million …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026